RLAY vs. AVGO

Last updated Jun 23, 2026

RLAY (Relay Therapeutics, Inc.) and AVGO (Broadcom Inc.) are both stocks. RLAY operates in Biotechnology (Healthcare), while AVGO operates in Semiconductors (Technology). Over the past 5 years, RLAY returned -12.73%/yr vs 55.97%/yr for AVGO. At a 0.26 correlation, their price movements are largely independent.

Performance

RLAY vs. AVGO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Relay Therapeutics, Inc. (RLAY) and Broadcom Inc. (AVGO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RLAY achieves a 104.26% return, which is significantly higher than AVGO's 13.72% return.

RLAY

• 1D: 8.82%
• 1M: 27.72%
• YTD: 104.26%
• 6M: 100.70%
• 1Y: 441.69%
• 3Y*: 13.34%
• 5Y*: -12.73%
• 10Y*: —

AVGO

• 1D: -4.52%
• 1M: -5.16%
• YTD: 13.72%
• 6M: 15.27%
• 1Y: 58.01%
• 3Y*: 70.37%
• 5Y*: 55.97%
• 10Y*: 42.25%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RLAY vs. AVGO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
RLAY Relay Therapeutics, Inc.	104.26%	105.34%	-62.58%	-26.31%	-51.35%	-26.11%	18.74%
AVGO Broadcom Inc.	13.72%	50.63%	110.49%	104.18%	-13.27%	56.48%	42.01%

Correlation

The correlation between RLAY and AVGO is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.23
Correlation (3Y) Calculated over the trailing 3-year period	0.24
Correlation (5Y) Calculated over the trailing 5-year period	0.28
Correlation (All Time) Calculated using the full available price history since Jul 16, 2020	0.26

Fundamentals

Market Cap RLAY : $3.11B AVGO : $1.91T
EPS RLAY : -$1.57 AVGO : $6.01
PS Ratio RLAY : 281.24 AVGO : 25.35
PB Ratio RLAY : 4.84 AVGO : 21.80
Total Revenue (TTM) RLAY : $10.68M AVGO : $75.47B
Gross Profit (TTM) RLAY : $6.33M AVGO : $50.53B
EBITDA (TTM) RLAY : -$285.68M AVGO : $42.03B

Return for Risk

RLAY vs. AVGO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RLAY

RLAY Risk / Return Rank: 98
RLAY Sharpe Ratio Rank: 99
RLAY Sortino Ratio Rank: 98
RLAY Omega Ratio Rank: 97
RLAY Calmar Ratio Rank: 99
RLAY Martin Ratio Rank: 99

AVGO

AVGO Risk / Return Rank: 75
AVGO Sharpe Ratio Rank: 78
AVGO Sortino Ratio Rank: 73
AVGO Omega Ratio Rank: 73
AVGO Calmar Ratio Rank: 76
AVGO Martin Ratio Rank: 75

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RLAY vs. AVGO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Relay Therapeutics, Inc. (RLAY) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	RLAY	AVGO	Difference
Sharpe ratio: Return per unit of total volatility	6.36	1.26	+5.11
Sortino ratio: Return per unit of downside risk	5.22	1.83	+3.39
Omega ratio: Gain probability vs. loss probability	1.62	1.24	+0.38
Calmar ratio: Return relative to maximum drawdown	15.82	2.03	+13.78
Martin ratio: Return relative to average drawdown	45.15	4.63	+40.52

RLAY vs. AVGO - Sharpe Ratio Comparison

The current RLAY Sharpe Ratio is 6.36, which is higher than the AVGO Sharpe Ratio of 1.26. The chart below compares the historical Sharpe Ratios of RLAY and AVGO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

RLAY vs. AVGO - Drawdown Comparison

The maximum RLAY drawdown since its inception was -96.75%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for RLAY and AVGO.

Drawdown Indicators

	RLAY	AVGO	Difference
Max Drawdown Largest peak-to-trough decline	-96.75%	-48.30%	-48.45%
Max Drawdown (1Y) Largest decline over 1 year	-28.15%	-28.67%	+0.52%
Max Drawdown (3Y) Largest decline over 3 years	-84.78%	-41.15%	-43.63%
Max Drawdown (5Y) Largest decline over 5 years	-94.74%	-41.15%	-53.59%
Max Drawdown (10Y) Largest decline over 10 years	—	-48.30%	—
Current Drawdown Current decline from peak	-71.92%	-18.44%	-53.48%
Average Drawdown Average peak-to-trough decline	-69.15%	-8.00%	-61.15%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.85%	12.57%	-2.72%

Volatility

RLAY vs. AVGO - Volatility Comparison

The current volatility for Relay Therapeutics, Inc. (RLAY) is 19.66%, while Broadcom Inc. (AVGO) has a volatility of 21.58%. This indicates that RLAY experiences smaller price fluctuations and is considered to be less risky than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RLAY	AVGO	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.66%	21.58%	-1.92%
Volatility (6M) Calculated over the trailing 6-month period	48.45%	33.32%	+15.13%
Volatility (1Y) Calculated over the trailing 1-year period	70.13%	46.48%	+23.65%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	78.47%	43.61%	+34.86%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	77.71%	39.64%	+38.07%

Dividends

RLAY vs. AVGO - Dividend Comparison

RLAY has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.65%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
AVGO Broadcom Inc.	0.65%	0.70%	0.94%	1.71%	3.02%	2.24%	3.05%	3.54%	3.11%	1.87%	1.43%	1.13%
RLAY Relay Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both RLAY and AVGO in my portfolio?

RLAY and AVGO have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RLAY or AVGO?

AVGO has higher volatility (21.58%) compared to RLAY (19.66%). In terms of maximum drawdown, RLAY dropped -96.75% vs AVGO's -48.30%.

Which has better risk-adjusted returns?

RLAY currently has the higher Sharpe Ratio (6.36 vs 1.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.